FDA calls for cease fire in aspirin and Tylenol ads
FDA Commissioner Kennedy asks Sterling Drug to halt one sided Bayer aspirin ads attacking Tylenol. He faults Tylenol for misquoting an FDA panel and warns liver damage risks from overdoses. He asks FTC to curb misleading ads in the $750 million OTC painkiller market. Tylenol leads with 21 percent market share and a $10 million annual ad budget.